Variant report
Variant | nsv825717 |
---|---|
Chromosome Location | chr11:3649638-3650306 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs572525578 | chr11:3649667-3649668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs575791411 | chr11:3649670-3649671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs550720108 | chr11:3649671-3649672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs61878490 | chr11:3649698-3649699 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs191329573 | chr11:3649709-3649710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs386749914 | chr11:3649730-3649731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145241978 | chr11:3649731-3649732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs113034965 | chr11:3649794-3649795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529857080 | chr11:3649801-3649802 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs543870216 | chr11:3649821-3649822 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547967966 | chr11:3649861-3649862 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs75150984 | chr11:3649910-3649911 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs548541973 | chr11:3649941-3649942 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs201378275 | chr11:3649983-3649984 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs140106983 | chr11:3649984-3649985 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs201977234 | chr11:3649996-3649997 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs530516335 | chr11:3650020-3650021 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs144878722 | chr11:3650043-3650044 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs373708147 | chr11:3650077-3650078 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs7108612 | chr11:3650086-3650087 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs548372842 | chr11:3650090-3650091 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534274745 | chr11:3650197-3650198 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs568184546 | chr11:3650225-3650226 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs74049409 | chr11:3650232-3650233 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs373892053 | chr11:3650238-3650239 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs537173550 | chr11:3650264-3650265 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs140849669 | chr11:3650303-3650304 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 19432969 | CNVD |
Alzheimer''s disease | 17576883 | CNVD |
Long-qt syndrome | 17576883 | CNVD |
Emphysema | 19352772 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 16608533 | CNVD |
Cancer | 21183584 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Neuroblastoma | 21124317 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Schizophrenia | 21399695 | CNVD |
Gastric cancer | 16891809 | CNVD |
Cancer | 17160897 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:3648200-3656200 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
2 | chr11:3648600-3649800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr11:3648600-3649800 | Weak transcription | NHDF-Ad | bronchial |
4 | chr11:3648600-3650000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr11:3648600-3650000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr11:3648800-3662800 | Weak transcription | Primary hematopoietic stem cells | blood |
7 | chr11:3649800-3650200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr11:3650000-3650200 | Enhancers | NHDF-Ad | bronchial |
9 | chr11:3650000-3650400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
10 | chr11:3650000-3650400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr11:3650200-3658400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |